tradingkey.logo
tradingkey.logo

Alzamend Neuro Initiates Phase Ii Clinical Trial Of Al001 "Lithium In Brain" Study In Patients With Bipolar Disorder In Collaboration With Massachusetts General Hospital

ReutersMar 16, 2026 12:17 PM

- Alzamend Neuro Inc ALZN.O:

  • ALZAMEND NEURO INITIATES PHASE II CLINICAL TRIAL OF AL001 "LITHIUM IN BRAIN" STUDY IN PATIENTS WITH BIPOLAR DISORDER IN COLLABORATION WITH MASSACHUSETTS GENERAL HOSPITAL

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI